(Q38307012)

English

Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials

scientific article published on 29 December 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

0 references

1 reference

Europe PubMed Central

Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials (English)

1 reference

Europe PubMed Central

2 September 2017

metabolic syndrome

1 reference

based on heuristic

inferred from title

type 2 diabetes

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Rudolf Hoermann

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557752%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557752%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

4

object named as

Bu B Yeap

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557752%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Mathis Grossmann

1

object named as

Mathis Grossmann

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557752%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

29 December 2014

1 reference

Europe PubMed Central

2 September 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557752%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

83

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557752%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557752%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

344-351

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557752%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Type 2 diabetes mellitus and testosterone: a meta-analysis study.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Testosterone and metabolic syndrome: a meta-analysis study

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the framingham heart study

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Testosterone and glucose metabolism in men: current concepts and controversies

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Low testosterone in men with type 2 diabetes: significance and treatment

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Use and abuse of HOMA modeling

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Low testosterone levels are common and associated with insulin resistance in men with diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Testosterone with dutasteride, but not anastrazole, improves insulin sensitivity in young obese men: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Effects of long-term testosterone therapy on patients with "diabesity": results of observational studies of pooled analyses in obese hypogonadal men with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Conducting Meta-Analyses in R with the metafor Package

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12664

21 January 2018

Identifiers

10.1111/CEN.12664

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557752%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557752%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38307012&oldid=1752901208"